Skip to Content

Current Oncology, Volume 32, Issue 1

2025 January - 55 articles

Cover Story: Glioblastoma (GBM) is a highly aggressive form of brain cancer with a median survival of 15–20 months. Recurrence is nearly universal, despite standard-of-care therapies. The heterogeneity within and between tumors complicates the understanding of resistance mechanisms, including immune escape. Molecular profiling of diverse tumor cell populations is crucial for improving treatment outcomes. Immune signatures, composed of CD markers and cytokines, may serve as molecular biomarkers in GBM patients. However, understanding how the immune system interacts with GBM is limited. In this review, we explore immune subsets in the brain, current data on immune signatures in GBM, and potential therapeutic implications, emphasizing the need for multi-omics analysis to identify non-invasive biomarkers for better treatment strategies. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (55)

  • Article
  • Open Access
2,868 Views
20 Pages

The PREPARE Study: Acceptability and Feasibility of a Telehealth Trimodal Prehabilitation Program for Women with Endometrial Neoplasia

  • Elise P. Legault,
  • Paula A. B. Ribeiro,
  • Danielle Moreau-Amaru,
  • Emmanuelle Robert,
  • Sara Forte,
  • Alain S. Comtois,
  • Vanessa Samouëlian and
  • François Tournoux

Patients with endometrial neoplasia (EN) often have multiple comorbidities and a higher surgical risk. Prehabilitation programs (PPs) combine various interventions to improve preoperative conditions and reduce impairment due to surgical stress. We co...

  • Article
  • Open Access
1,883 Views
15 Pages

MicroRNA-129-3p Suppresses Tumor Progression and Chemoradioresistance in Head and Neck Squamous Cell Carcinoma

  • Tae Mi Yoon,
  • Sun-Ae Kim,
  • Eun Kyung Jung,
  • Young-Kook Kim,
  • Kyung-Hwa Lee and
  • Sang Chul Lim

(1) Background: MicroRNA-129 (miR-129) participates in tumor progression and chemoresistance in various cancer types. In this study, the role of miR-129-3p, the main mature form of miR-129, in tumor progression and chemoradiotherapy resistance in hea...

  • Systematic Review
  • Open Access
3 Citations
5,423 Views
30 Pages

Systematic Review and Network Meta-Analysis on Treating Hormone Receptor-Positive Metastatic Breast Cancer After CDK4/6 Inhibitors

  • Neha Pathak,
  • Abhenil Mittal,
  • Sudhir Kumar,
  • Chitrakshi Nagpal,
  • Eitan Amir,
  • Partha Haldar,
  • Bharath B. Gangadharaiah,
  • Akash Kumar,
  • Ashutosh Mishra and
  • Atul Batra

Introduction: The optimal treatment of estrogen receptor-positive (ER +) metastatic breast cancer (MBC) after progression on cyclin-dependent 4/6 kinase inhibitors (CDK4/6i) is unknown. Methods: We conducted a systematic review and network meta-analy...

  • Communication
  • Open Access
2 Citations
4,138 Views
8 Pages

Real-World Experience with CDK4/6 Inhibitors in the First-Line Palliative Setting for HR+/HER2− Advanced Breast Cancer

  • Ram Patel,
  • John Mathews,
  • Caroline Hamm,
  • Swati Kulkarni,
  • Rasna Gupta,
  • Tarquin Opperman,
  • John Dean Chiong and
  • Abdullah Nasser

Introduction: CDK4/6 inhibitors in combination with aromatase inhibitors (AIs) are the standard first-line treatment for hormone receptor-positive (HR+), HER2-negative (HER2−) metastatic breast cancer. Landmark trials have demonstrated a compar...

  • Article
  • Open Access
3 Citations
2,401 Views
14 Pages

TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization

  • Ken Zhao,
  • Anita Karimi,
  • Luke Kelly,
  • Elena Petre,
  • Brett Marinelli,
  • Erica S. Alexander,
  • Vlasios S. Sotirchos,
  • Joseph P. Erinjeri,
  • Anne Covey and
  • Hooman Yarmohammadi
  • + 6 authors

The aim of this study was to evaluate associations between TP53 status and outcomes after transarterial embolization (TAE) for the treatment of patients with hepatocellular carcinoma (HCC). This single-institution study included patients from 1/2014...

  • Case Report
  • Open Access
2,349 Views
6 Pages

Extensive Morphea Following Adjuvant Radiotherapy for Breast Carcinoma—Case Report

  • Alexandru Panaitescu,
  • Hannah Nguyen,
  • Laurence Masson-Côté and
  • Carolina Lucena Fernandes

Radiation-induced morphea (RIM) is a rare complication following radiotherapy (RT) for breast cancer treatment. Its distribution is usually confined to the breast having received radiotherapy. A generalized form of RIM also exists, defined as lesions...

  • Article
  • Open Access
3 Citations
2,757 Views
12 Pages

Advancing Radiobiology: Investigating the Effects of Photon, Proton, and Carbon-Ion Irradiation on PANC-1 Cells in 2D and 3D Tumor Models

  • Alexandra Charalampopoulou,
  • Amelia Barcellini,
  • Giuseppe Magro,
  • Anna Bellini,
  • Sara Sevan Borgna,
  • Giorgia Fulgini,
  • Giovanni Battista Ivaldi,
  • Alessio Mereghetti,
  • Ester Orlandi and
  • Angelica Facoetti
  • + 4 authors

Introduction: Pancreatic cancer (PC) is one of the most aggressive and lethal malignancies, calling for enhanced research. Pancreatic ductal adenocarcinoma (PDAC) represents 70–80% of all cases and is known for its resistance to conventional th...

  • Review
  • Open Access
1 Citations
3,878 Views
19 Pages

A Canadian Perspective on Systemic Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma

  • Anna Spreafico,
  • Eric Winquist,
  • Cheryl Ho,
  • Brian O’Sullivan,
  • Nathaniel Bouganim,
  • Neil Chua,
  • Sarah Doucette,
  • Lillian L. Siu and
  • Desiree Hao

Although the majority of patients with nasopharyngeal carcinoma (NPC) present with early-stage or locoregional disease that can be treated with definitive radiotherapy, approximately 20% of patients experience disease recurrence, and 15% present with...

  • Review
  • Open Access
6 Citations
4,506 Views
29 Pages

Towards Personalized Radiotherapy in Pelvic Cancer: Patient-Related Risk Factors for Late Radiation Toxicity

  • Anna C. Nuijens,
  • Arlene L. Oei,
  • Nicolaas A. P. Franken,
  • Coen R. N. Rasch and
  • Lukas J. A. Stalpers

Normal tissue reactions vary significantly among patients receiving the same radiation treatment regimen, reflecting the multifactorial etiology of late radiation toxicity. Predicting late radiation toxicity is crucial, as it aids in the initial deci...

  • Systematic Review
  • Open Access
1 Citations
4,021 Views
11 Pages

Background: Immune checkpoint inhibitors (ICIs), either alone or in combination with platinum-based chemotherapy, are effective in the first-line treatment of metastatic, non-oncogene-addicted, non-small cell lung cancer (NSCLC). However, when NSCLC...

  • Article
  • Open Access
1,780 Views
13 Pages

Perspectives of Women with Breast Cancer and Healthcare Providers Participating in an Adherence-Enhancing Program for Adjuvant Endocrine Therapy: A Qualitative Study

  • Véronique Turcotte,
  • Laurence Guillaumie,
  • Martine Lemay,
  • Anne Dionne,
  • Julie Lemieux,
  • Angéline Labbé,
  • Carolyn Gotay,
  • Line Guénette and
  • Sophie Lauzier

Background: Adjuvant endocrine therapy (AET) is prescribed for 5–10 years to women with hormone-sensitive breast cancer to prevent recurrence. However, a significant proportion of women do not adhere to AET. We developed SOIE, a one-year progra...

  • Review
  • Open Access
3 Citations
6,670 Views
17 Pages

Mutations in isocitrate dehydrogenase (IDH) genes are among the most frequently encountered molecular alterations in cholangiocarcinoma (CCA). These neomorphic point mutations endow mutant IDH (mIDH) with the ability to generate an R-enantiomer of 2-...

  • Article
  • Open Access
2 Citations
2,826 Views
14 Pages

Background: The diagnosis and treatment of cancer are associated with substantial physical, psychological, and social morbidity for most patients. Distress can be seen as an unpleasant experience of an emotional, psychological, social, or spiritual n...

  • Article
  • Open Access
1 Citations
2,674 Views
13 Pages

Impact of Bone-Modifying Agents on Post-Bone Metastasis Survival Across Cancer Types

  • Hironari Tamiya,
  • Kazumi Nishino,
  • Yuji Kato,
  • Reina Nakahashi-Kato,
  • Yurika Kosuga-Tsujimoto,
  • Shota Kinoshita,
  • Rie Suzuki,
  • Makiyo Watanabe,
  • Toru Wakamatsu and
  • Satoshi Takenaka
  • + 1 author

Background: Bone metastasis is associated with a poor prognosis. Bone-modifying agents (BMA) are commonly used for the prevention or treatment of skeletal-related events (SRE) in patients with bone metastasis; however, whether or not treatment with B...

  • Case Report
  • Open Access
1 Citations
3,408 Views
19 Pages

A Journey into the Complexity of Temporo-Insular Gliomas: Case Report and Literature Review

  • Manuel De Jesus Encarnacion Ramirez,
  • Gervith Reyes Soto and
  • Carlos Castillo Rangel

Introduction: Temporo-insular gliomas, rare brain tumors originating from glial cells, comprise about 30% of brain tumors and vary in aggressiveness from grade I to IV. Despite advancements in neuroimaging and surgical techniques, their management re...

  • Review
  • Open Access
3 Citations
4,527 Views
12 Pages

The EASL diagnostic algorithm for hepatocellular carcinoma, currently in use, dates back to 2018. While awaiting its update, numerous advancements have emerged in the field of hepatocellular carcinoma imaging. These innovations impact every step of t...

  • Article
  • Open Access
6 Citations
2,419 Views
14 Pages

Comprehensive Evaluation of Inflammatory Biomarkers in Cervical Cancer Treated with Chemoradiotherapy

  • Timur Koca,
  • Nurcihan Gocen Vardar,
  • Rahmi Atıl Aksoy and
  • Aylin Fidan Korcum

Objective: Inflammatory biomarkers have been shown to possess both prognostic and predictive significance in various cancers. Among the emerging biomarkers, the pan-immune-inflammation value (PIV) has recently been introduced as a novel indicator rep...

  • Article
  • Open Access
1,387 Views
11 Pages

Treatment Outcomes in Spinal Tumors According to Patients’ Perspectives: A Focus on Indeterminate Spinal Instability

  • Victoria H. Schimmelpenning,
  • Robin Brugger,
  • Nikki Rommers,
  • Johann Kunst,
  • Martin Jäger,
  • Christoph E. Albers and
  • Helena Milavec

The objective of this study was to analyze treatment approaches and outcomes according to patients’ perspectives for patients with indeterminate spinal instability caused by neoplastic lesions. Data were collected from 31 patients with a total...

  • Case Report
  • Open Access
1,384 Views
8 Pages

Insights into the Multidisciplinary Approach for Metastatic Acinic Cell Lung Carcinoma: The Pathologist’s Role in Romania Today

  • Dorela-Codruta Lazureanu,
  • Amelia Burlea,
  • Robert Barna,
  • Daniela Cipu,
  • Mihaela Pasca Fenesan,
  • Ioan Icma and
  • Marioara Cornianu

Background/Objectives: Acinic cell carcinoma (ACC) is a rare lung neoplasm that can affect both children and adults as a parenchymal or endobronchial mass. It is histologically similar to this kind of tumor described in salivary glands, but with a di...

  • Article
  • Open Access
4,202 Views
15 Pages

Background: Afatinib and Osimertinib are first-line treatments for EGFR-mutated advanced non-small cell lung cancer (NSCLC), but their comparative efficacies and the patient groups that benefit the most remain unclear. This multicenter retrospective...

  • Article
  • Open Access
3 Citations
3,715 Views
23 Pages

Single-Cell RNA Sequencing Reveals LEF1-Driven Wnt Pathway Activation as a Shared Oncogenic Program in Hepatoblastoma and Medulloblastoma

  • Christophe Desterke,
  • Yuanji Fu,
  • Jenny Bonifacio-Mundaca,
  • Claudia Monge,
  • Pascal Pineau,
  • Jorge Mata-Garrido and
  • Raquel Francés

(1) Background: Hepatoblastoma and medulloblastoma are two types of pediatric tumors with embryonic origins. Both tumor types can exhibit genetic alterations that affect the β-catenin and Wnt pathways; (2) Materials and Methods: This study used...

  • Article
  • Open Access
1 Citations
1,751 Views
15 Pages

Targeted Transition Readiness Workshops for Pediatric Brain Tumor Survivors: Feasibility, Acceptability, and Preliminary Effects

  • Julie Carrier,
  • Tziona Lugasi,
  • Nathalie Labonté,
  • Carole Provost,
  • Andrea Saragosti,
  • Claire Longpré,
  • Bénédicte Koukoui,
  • Émilie Régnier-Trudeau,
  • Serge Sultan and
  • Leandra Desjardins
  • + 3 authors

Pediatric brain tumor survivors (PBTS) are at risk for late effects related to their diagnosis and treatment. Long-term medical follow-ups are deemed essential, implying a transition from pediatric to adult healthcare settings. This pilot study aims...

  • Article
  • Open Access
1 Citations
2,184 Views
11 Pages

Engaging Nurses in Effective Cost of Care Conversations to Address Cancer-Related Financial Toxicity: Results from an Exploratory Survey

  • Jean S. Edward,
  • Amanda Thaxton Wiggins,
  • Louis G. Baser,
  • Haafsah Fariduddin,
  • Joanna F. Doran,
  • Monica F. Bryant,
  • John A. D’Orazio and
  • Kimberly D. Northrip

Few evidence-based trainings exist on how to equip healthcare providers, particularly nurses, with the skills to engage in cost of care conversations with patients/caregivers to mitigate the impact of cancer-related financial toxicity. This study eva...

  • Article
  • Open Access
2,238 Views
11 Pages

Initial Treatment Modalities in Patients with Newly Diagnosed Primary Lung Cancer in Japan

  • Qingqing Hu,
  • Kuan-Chih Huang,
  • Ko Nakajo,
  • Yongjing Zhang and
  • Hong Qiu

Treatment for lung cancer continues to rapidly evolve. Here, we describe trends in the initial treatment of adults with newly diagnosed primary non-small-cell lung cancer in Japan. This retrospective cohort study used data from JMDC Inc. Claims Datab...

  • Article
  • Open Access
1 Citations
1,677 Views
12 Pages

Long-Term Oncological Outcomes Related to Lymphadenectomy in Clinical Stage I NSCLC: A Multicenter Retrospective Experience

  • Beatrice Manfredini,
  • Carmelina Cristina Zirafa,
  • Alessandro Stefani,
  • Gaetano Romano,
  • Greta Alì,
  • Riccardo Morganti,
  • Ilaria Ceccarelli,
  • Federico Davini,
  • Pier Luigi Filosso and
  • Franca Melfi

Background: Lymphadenectomy is considered a key part of the radical treatment of resectable lung cancer, although its appropriate extension in early stages is a debated topic due to the great heterogeneity of studies in the literature. This study aim...

  • Article
  • Open Access
1 Citations
1,662 Views
16 Pages

Deep-Learning-Based Reconstruction of Single-Breath-Hold 3 mm HASTE Improves Abdominal Image Quality and Reduces Acquisition Time: A Quantitative Analysis

  • Felix Kubicka,
  • Qinxuan Tan,
  • Tom Meyer,
  • Dominik Nickel,
  • Elisabeth Weiland,
  • Moritz Wagner and
  • Stephan Rodrigo Marticorena Garcia

Purpose: Breath-hold T2-weighted half-Fourier acquisition single-shot turbo spin echo (HASTE) magnetic resonance imaging (MRI) of the upper abdomen with a slice thickness below 5 mm suffers from high image noise and blurring. The purpose of this pros...

  • Article
  • Open Access
2,175 Views
15 Pages

Purpose: To evaluate the diagnostic value of ultrasound radiomics in distinguishing between benign and malignant breast nodules in women who have undergone silicone breast augmentation. Methods: A retrospective study was conducted of 99 breast nodule...

  • Article
  • Open Access
1,791 Views
10 Pages

Comparison of CT-Guided Microwave Ablation of Liver Malignancies with and Without Intra-Arterial Catheter Placement for Contrast Administration

  • Anne Bettina Beeskow,
  • Holger Gößmann,
  • Hans-Jonas Meyer,
  • Daniel Seehofer,
  • Thomas Berg,
  • Florian van Bömmel,
  • Aaron Schindler,
  • Manuel Florian Struck,
  • Timm Denecke and
  • Sebastian Ebel

Background: The aim of this study was to compare microwave ablation (MWA) with and without prior placement of an intra-arterial catheter for the purpose of application of contrast medium (CM). Methods: 148 patients (45 female, 65.1 ± 14.9 year...

  • Article
  • Open Access
1 Citations
2,396 Views
16 Pages

Feasibility and Preliminary Effects of Acupuncture for Cognitive Dysfunction in Diverse Cancer Survivors: A Pilot, Randomized, Placebo-Controlled Trial

  • Xiaotong Li,
  • Kaitlin Lampson,
  • Tim A. Ahles,
  • James C. Root,
  • Q. Susan Li,
  • Yuelin Li,
  • Anam Ahsan,
  • Jun J. Mao and
  • Kevin T. Liou

(1) Background: This pilot study evaluates the feasibility and preliminary effects of acupuncture for cancer-related cognitive dysfunction (CRCD) in cancer survivors. (2) Methods: A randomized trial comparing real acupuncture (RA) to sham acupuncture...

  • Article
  • Open Access
1,634 Views
17 Pages

(1) Background: Volumetric modulated arc therapy (VMAT) can deliver more accurate dose distribution and reduce radiotherapy-induced toxicities for postoperative cervical and endometrial cancer. This study aims to retrospectively analyze the relations...

  • Article
  • Open Access
1 Citations
1,758 Views
12 Pages

Necrosis in Preoperative Cross-Sectional Imaging and Postoperative Histology Is a Diagnostic Marker for Malignancy of Adrenocortical Tumors

  • Agata Dukaczewska,
  • Stephan R. Marticorena Garcia,
  • Simon Ponsel,
  • Alexandra Webster,
  • Frederike Butz,
  • Eva M. Dobrindt,
  • Johann Pratschke,
  • Peter E. Goretzki,
  • David Horst and
  • Catarina A. Kunze
  • + 1 author

Necrosis in postoperative histology has been reported as being specific for adrenocortical carcinoma (ACC) compared to adenoma. We therefore retrospectively analyzed the diagnostic accuracy of the finding of necrosis in preoperative cross-sectional i...

  • Review
  • Open Access
2 Citations
3,264 Views
20 Pages

Biliary tract cancers (BTC) are a highly heterogeneous group of cancers at the genomic, epigenetic and molecular levels. The vast majority of patients initially present at an advanced (unresectable) disease stage due to a lack of symptoms and an aggr...

  • Article
  • Open Access
2,294 Views
12 Pages

Background: This study aimed to explore the experience of financial toxicity in patients with colorectal cancer during chemotherapy and to inform the development of targeted interventions. Methods: A descriptive qualitative research method was used t...

  • Review
  • Open Access
3,706 Views
31 Pages

Pain and Frailty in Childhood Cancer Survivors: A Narrative Review

  • Chiara Papini,
  • Jaspreet K. Sodhi,
  • Cassie M. Argenbright,
  • Kirsten K. Ness and
  • Tara M. Brinkman

A significant proportion of childhood cancer survivors experience persistent health problems related to cancer or cancer treatment exposures, including accelerated or early onset of aging. Survivors are more likely than non-cancer peers to present a...

  • Article
  • Open Access
4 Citations
1,843 Views
11 Pages

Role of Age, Comorbidity, and Frailty in the Prediction of Postoperative Complications After Surgery for Vulvar Cancer: A Retrospective Cohort Study with the Development of a Nomogram

  • Giovanni Delli Carpini,
  • Francesco Sopracordevole,
  • Camilla Cicoli,
  • Marco Bernardi,
  • Lucia Giuliani,
  • Mariasole Fichera,
  • Nicolò Clemente,
  • Anna Del Fabro,
  • Jacopo Di Giuseppe and
  • Andrea Ciavattini
  • + 2 authors

Surgery is the cornerstone of vulvar cancer treatment, but it is associated with a significant risk of complications that may impact prognosis, particularly in older patients with multiple comorbidities. The objective of this study was to evaluate th...

  • Article
  • Open Access
2,496 Views
12 Pages

Implementation of a Hepatitis B Screening Program in Patients Receiving Systemic Anti-Cancer Therapy

  • Jennifer Leigh,
  • Ranjeeta Mallick,
  • Stephanie Brule,
  • Lisa Rambout,
  • Jennifer Newton,
  • Dominick Bossé,
  • Curtis Cooper and
  • Joanna Gotfrit

Cancer patients receiving non-endocrine therapies are at risk of hepatitis B virus (HBV) reactivation (HBVr). Guidelines recommend HBV screening prior to treatment. The Ottawa Hospital Cancer Center implemented a screening pilot for all patients rece...

  • Review
  • Open Access
6 Citations
3,524 Views
13 Pages

Laryngeal cancer is one of the main causes of morbidity and mortality worldwide, with a significantly higher prevalence among men than women. However, the incidence, clinical characteristics, and specific treatment of laryngeal cancer in women have o...

  • Article
  • Open Access
2,257 Views
11 Pages

Retrospective, Non-Interventional, Multicenter Study on the Effectiveness and Safety of Intravesical Bacillus Calmette–Guerin in Patients with Non-Muscle-Invasive Bladder Cancer: Real-World Experience from Six Hospital Centers in Greece

  • Panagiotis Angelopoulos,
  • Titos Markopoulos,
  • Lazaros Lazarou,
  • Andreas Skolarikos,
  • Panagiotis Stamatakos,
  • Georgios I. Papadopoulos,
  • Charalampos Fragkoulis,
  • Konstantinos Ntoumas,
  • Napoleon Moulavasilis and
  • Dionysios Mitropoulos
  • + 14 authors

Background: While the clinical application of SII-ONCO-Bacillus Calmette–Guerin (BCG) for non-muscle-invasive bladder cancer (NMIBC) is well established in Greece, there is a lack of real-world data on its effectiveness and safety. This retrosp...

  • Article
  • Open Access
2,344 Views
11 Pages

Risk Factors for Postoperative Nausea and Vomiting After TACE: A Prospective Cohort Study

  • Yuzhu Wang,
  • Xin Zhou,
  • Guoping Li,
  • Qianzhou Lv,
  • Xiaoyu Li and
  • Zhiping Yan

Objective: Postoperative nausea and vomiting (PONV) was one of the common complications in patients with HCC who had undergone TACE. This study was a prospective analysis of patient data to investigate risk factors for PONV in patients after TACE. Ma...

  • Review
  • Open Access
2 Citations
2,555 Views
23 Pages

Glioblastoma (GBM) is a primary central nervous system malignancy with a median survival of 15–20 months. The presence of both intra- and intertumoral heterogeneity limits understanding of biological mechanisms leading to tumor resistance, incl...

  • Review
  • Open Access
9 Citations
8,630 Views
12 Pages

Focal Therapy for Prostate Cancer: Recent Advances and Insights

  • Francesco Lasorsa,
  • Arianna Biasatti,
  • Angelo Orsini,
  • Gabriele Bignante,
  • Gabriana M. Farah,
  • Savio Domenico Pandolfo,
  • Luca Lambertini,
  • Deepika Reddy,
  • Rocco Damiano and
  • Srinivas Vourganti
  • + 3 authors

Focal therapy has emerged as a balanced middle ground aiming to reduce overtreatment and the risk of progression, as well as patients’ distress and anxiety. Focal therapy and partial gland ablation prioritize the precise elimination of the inde...

  • Commentary
  • Open Access
7 Citations
4,186 Views
14 Pages

Building a Genomics-Informed Nursing Workforce: Recommendations for Oncology Nursing Practice and Beyond

  • Jacqueline Limoges,
  • Rebecca Puddester,
  • Andrea Gretchev,
  • Patrick Chiu,
  • Kathy Calzone,
  • Kathleen Leslie,
  • April Pike and
  • Nicole Letourneau

Background: Genomics is a foundational element of precision health and can be used to identify inherited cancers, cancer related risks, therapeutic decisions, and to address health disparities. However, there are structural barriers across the cancer...

  • Article
  • Open Access
6 Citations
3,229 Views
27 Pages

The treatment landscape for patients with advanced ALK-positive NSCLC has rapidly evolved following the approval of several ALK TKIs in Canada. However, public funding of ALK TKIs is mostly limited to the first line treatment setting. Using linked pr...

  • Article
  • Open Access
2,673 Views
14 Pages

Open Partial Horizontal Laryngectomy as a Conservative Salvage Treatment for Laser-Recurrent Laryngeal Cancer: A Multi-Institutional Series

  • Erika Crosetti,
  • Andrea Borello,
  • Andy Bertolin,
  • Izabela Costa Santos,
  • Marco Fantini,
  • Giulia Arrigoni,
  • Ilaria Bertotto,
  • Andrea Elio Sprio,
  • Fernando Luiz Dias and
  • Giovanni Succo
  • + 1 author

Early-stage laryngeal cancer (T1-T2) is commonly treated with organ-preserving techniques such as transoral laser microsurgery (TOLMS) or radiation therapy (RT), both providing comparable oncological outcomes but differing in functional results. Loca...

  • Article
  • Open Access
3 Citations
10,435 Views
9 Pages

Real-World Efficacy and Safety of Avelumab Plus Axitinib in Metastatic Renal Cell Carcinoma: Results from the Ambispective RAVE-Renal Study

  • Ilya Tsimafeyeu,
  • Vyacheslav Chubenko,
  • Olga Baklanova,
  • Alexey Kalpinskiy,
  • Sufia Safina,
  • Andrei Lebedinets,
  • Vladislav Petkau,
  • Elvira Parsadanova,
  • Maria Turganova and
  • Rashida Orlova
  • + 7 authors

Background: The RAVE-Renal study was conducted to evaluate the real-world efficacy and safety of avelumab plus axitinib as a first-line therapy for patients with metastatic renal cell carcinoma (mRCC). Methods: RAVE-Renal was a multicenter, noninterv...

  • Brief Report
  • Open Access
4 Citations
1,144 Views
6 Pages

Matched Unrelated Donor Hematopoietic Cell Transplantation: Increased Usage and Improvements in Clinical Outcomes in Canada

  • Matthew D. Seftel,
  • Grace Musto,
  • David Allan,
  • Oliver Bucher,
  • Kevin Hay,
  • Ivan Pasic,
  • Tony Truong and
  • Kristjan Paulson

In allogeneic hematopoietic cell transplantation (HCT), a minority of patients have access to a suitable human leukocyte antigen (HLA)-matched related donor (MRD). To fill this gap, matched unrelated donors (MUDs) are an increasingly selected donor s...

  • Article
  • Open Access
1 Citations
2,096 Views
9 Pages

Focal therapy offers a promising approach for treating localized prostate cancer (PC) with minimal invasiveness and potential cost benefits. High-intensity focused ultrasound (HIFU) and brachytherapy (BT) are among these options but lack long-term ef...

  • Review
  • Open Access
4 Citations
3,184 Views
19 Pages

Optimal Pathways to Lung Cancer Screening in Primary Care Settings: A Scoping Review

  • Emmanouil K. Symvoulakis,
  • Izolde Bouloukaki,
  • Antonios Christodoulakis,
  • Antonia Aravantinou-Karlatou and
  • Ioanna Tsiligianni

Lung cancer is the leading cause of cancer-related deaths worldwide, and delayed detection contributes to poor outcomes. Primary care plays a crucial role in early diagnosis, but detecting lung cancer early remains challenging for general practitione...

  • Article
  • Open Access
4 Citations
5,374 Views
12 Pages

Background: Since 2023, ChatGPT-4 has been impactful across several sectors including healthcare, where it aids in medical information analysis and education. Electronic patient-reported outcomes (ePROs) play a crucial role in monitoring cancer patie...

  • Article
  • Open Access
5,003 Views
20 Pages

A Real-World Comparison Between Adjuvant Docetaxel with Cyclophosphamide (TC) and Anthracycline–Taxane Chemotherapy in Early HER-2 Negative Breast Cancer

  • Danilo Giffoni de Mello Morais Mata,
  • Rossanna C. Pezo,
  • Kelvin K. W. Chan,
  • Ines Menjak,
  • Andrea Eisen and
  • Maureen Trudeau

Background: Anthracycline–taxane chemotherapy is the gold standard in high-risk breast cancer (BC), despite the potential risk of congestive heart failure (CHF). A suitable alternative for anthracycline-sparing chemotherapy is through the combi...

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729